Tow truck driver arrested in St. Pete crash that killed 2, injured boy
A tow truck driver has been arrested on vehicular homicide charges in connection with an October crash in St. Petersburg that killed two adults and seriously injured a 9-year-old boy.
George Phillip Aponte, 45, of Clearwater, was arrested Tuesday in connection with the incident, which occurred Oct. 15 on 5th Avenue South near 20th Street South.
The crash occurred about 5 p.m. that day as Aponte drove west on 5th Avenue South. His truck hit a Honda CR-V driven by Shakesha Desence, 35, who had been making a left onto 5th Avenue from 20th Street South, police said.
Desence was taken to a hospital and pronounced dead. Her passenger, Dilean Desence, 72, died at the scene. His 9-year-old grandson, who was also a passenger in the vehicle, was taken to Johns Hopkins All Children's Hospital and was initially listed in critical condition. The boy was later released from the hospital but 'continues to mend from his injuries,' police said in a news release Tuesday announcing Aponte's arrest.
Aponte is facing two charges of vehicular homicide and one count of reckless driving causing injury. He was being held at the Pinellas County Jail Tuesday; bail information was not yet available.
An arrest affidavit also was not immediately available on Tuesday to provide details about what gave police probable cause to arrest Aponte.
Records show Aponte has been cited at least nine times in Pinellas County since 2020. They include three citations for careless driving and two for driving 10 to 14 miles per hour over the speed limit.
In January, about three months after the crash, St. Petersburg police cited Aponte for driving 55 mph in a 35-mph zone on Freemont Terrace South near 34th Street, records show. Aponte pleaded no contest in March and a judge ordered him to complete a driver improvement course within 60 days, which he failed to do, records show.
Court records say Aponte was employed by A-1 Recovery at the time of the crash.
A person who answered the phone at A-1 Recovery Tuesday said no one was available to speak with a reporter and provided the name of the company's attorney. The attorney did not immediately return a voicemail message.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
THC Gummies Linked To Prosper Graduation Celebration Hospitalizations
Two teenagers face second-degree felony charges after distributing THC-infused gummies at a Prosper graduation party last month. The gummies, which led to overdose-like symptoms and hospital visits for at least seven attendees, were purchased from a Plano smoke shop, according to arrest warrants obtained from the Prosper Police Department. Kyle Muchineuta, 17, of Prosper, and Cesar Omana, 18, of Frisco, are charged with the manufacture and delivery of a controlled substance. Records from the schools' graduation programs indicate Muchineuta attended Walnut Grove High School, while Omana attended Rock Hill High School. The incident occurred at the Prosper Graduation Celebration, held from 11 p.m. on Friday, May 16, to 3 a.m. on Saturday, May 17, at 3R's Ranch in Prosper. The event, organized by a nonprofit and not affiliated with Prosper ISD, is traditionally alcohol—and drug-free. It offers games, dancing, music, and food for seniors from Prosper's three high schools. According to the warrants, Muchineuta and Omana purchased the THC-infused gummies from A&A Smoke Shop at 3620 State Highway 121 in Plano, CBS News Texas reported. Victims paid Omana via a cash app for the edibles, which the teens then distributed at the party. Nine attendees ingested the gummies, with eight requiring hospital transport after exhibiting overdose-like symptoms. At least seven students were hospitalized. Prosper police responded to the ranch around 2:15 a.m. on May 17. The town said in a written statement, 'Paramedics from Prosper, Celina, and Frisco treated multiple individuals experiencing medical distress and transported eight patients to local hospitals.' Allan Haji, founder and owner of A&A Smoke Shop, defended his business's practices, stating, 'We do not sell to minors. Period. This isn't just a guideline—it's a non-negotiable rule that we enforce with the utmost seriousness. Every team member is trained and held accountable to verify IDs without exception.' 'If there was any breach of this policy, I will personally take full responsibility to investigate and correct it immediately,' Haji added, per CBS News. He noted that no police officers have contacted him or requested purchase records. The legal age to purchase Delta-8-THC products in Texas without a medical prescription is 21. However, the Texas Legislature passed Senate Bill 3 last month, which would ban the sale of all THC products. Farmers, veterans, and small business owners have urged Gov. Greg Abbott to veto the bill, but if he chooses to sign the measure or allows it to pass into law without a signature, it will become effective September 1, 2025. Prosper ISD informed parents about the incident, clarifying that the event was not district-affiliated and occurred off district property. 'While we cannot provide specific details, several young adults experienced medical emergencies and required transport from the event,' the district said. 'The Town of Prosper responded quickly, and Graduation Celebration ended early. All affected young adults are receiving appropriate medical care.' On Thursday, Prosper ISD declined further comment and deferred decisions about next year's event to the graduation celebration committee.
Newsweek
4 hours ago
- Newsweek
Bear Breaks Into Family's Backyard, Nobody Prepared for What It Does Next
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A Los Angeles homeowner was stunned when a black bear entered their backyard, but it is what the animal did next that has shocked internet users. In a viral TikTok video shared on Saturday under the username @laurenaurora, the bear is filmed walking around the yard as if he owns the place, before proceeding to jump inside the family's pool for a refreshing splash. The poster and her mom can be heard in the background, discussing about calling the police, while the unaware bear freshens up in the 90-degree Fahrenheit heat. "Excuse my mom and I's commentary, but it's not every day that you see a bear in your backyard. This bear was most likely displaced from the Eaton fires, but enjoy this cute clip of it cooling off in my pool," the caption says. The California Department of Fish and Wildlife says that black bears are the only wild bears in the state, but they do come in different colors, from solid shades of black to lighter ones of brown and tan. With over 35,000 specimens, California has the second-highest black bear population in the whole country, following Alaska, which has 100,000. Although rare, bear attacks can and do happen, which is why you should exercise caution around them. WebMD says that, if a bear has noticed you and looks threatening, there are things you can do to de-escalate the situation. The first thing to do is stay calm. Do not run away, as this can make the bear think you are prey. If you're in a group, gather everyone together and pick up any small children. You can try talking to the bear calmly so it knows you are human and back away slowly, trying to avoid any unnecessary interaction. However, if the bear starts to approach, WebMD says you should make yourself as big as possible by stretching your arms over your head and making loud noises. If it charges at you, it is time to use bear spray, which you should take with you in areas densely populated by bears. Stock image: A young black bear stands by a tree in the backyard, looking into the window. Stock image: A young black bear stands by a tree in the backyard, looking into the window. getty images The video quickly went viral on social media and has so far received over 882,500 views and more than 83,600 likes on the platform. One user, A. commented: "If this happened in MY backyard, I would cancel my entire day and just watch that beautiful creature and let him do whatever he wants and pray that he's ok." Casey posted: "Immediately disappointed we don't have more bear in pool footage." Angiehall6082 added: "He's so hot and miserable. Please just let him cool off. He will go away after he has a little swim." Newsweek reached out to @laurenaurora for comment via TikTok comments. We could not verify the details of the case. Do you have funny and adorable videos or pictures of your pet you want to share? Send them to life@ with some details about your best friend, and they could appear in our Pet of the Week lineup.
Business Wire
8 hours ago
- Business Wire
OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma
NEW YORK--(BUSINESS WIRE)-- OS Therapies Inc. (NYSE-A: OSTX) ('OS Therapies' or 'the Company'), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced it has submitted a request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the prevention of metastases in recurrent, fully-resected, lung metastatic pediatric osteosarcoma. RMAT designations are granted to sponsors with regenerative medicine therapies for serious or life-threatening conditions and provide sponsors with various benefits, including eligibility for an accelerated Biologics License Application (BLA) review. OST-HER2 has already received Rare Pediatric Disease Designation (RPDD), Orphan Drug Designation (ODD) and Fast Track Designation (FTD) for osteosarcoma from the U.S. FDA. If OST-HER2 receives a conditional BLA via Accelerated Review prior to September 30, 2026, the Company will become eligible to receive a Priority Review Voucher (PRV) that it intends to immediately sell. The most recent publicly disclosed PRV sale, valued at $155 million, occurred in May 2025. The Company is awaiting feedback by mid-June 2025 from a Type D meeting with FDA regarding the statistical analysis plan to be used in an End of Phase 2 meeting for OST-HER2 in the prevention of metastases in recurrent, fully-resected, lung metastatic pediatric osteosarcoma. Upon receipt of the Type D Meeting feedback, the Company intends to promptly request the End of Phase 2 meeting with FDA in which it will be seek agreement to allow it to begin a rolling BLA submission in the third quarter of 2025. The grant of the RMAT designation in the third quarter of 2025 complements the company's parallel efforts in other major markets, including Europe and the United Kingdom, where the company plans to seek EMA PRIME Designation and Conditional Market Access (CMA) applications. In parallel to regulatory engagement and market access planning for OST-HER2, the Company is preparing for the late stage clinical development of other pipeline candidates. As such, the Company is well positioned for sustained growth across multiple therapeutic modalities. About OS Therapies OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors. OST-HER2, the Company's lead asset, is an immunotherapy leveraging the immune-stimulatory effects of Listeria bacteria to initiate a strong immune response targeting the HER2 protein. OST-HER2 has received Rare Pediatric Disease Designation (RPDD) from the U.S. Food & Drug Administration and Fast-Track and Orphan Drug designations from the U.S. FDA and European Medicines Agency. The Company has demonstrated positive data in its Phase 2b clinical trial of OST-HER2 in recurrent, fully resected, lung metastatic osteosarcoma demonstrating statistically significant benefit in the 12-month event free survival (EFS) primary endpoint of the study. The Company anticipates submitting a BLA to the U.S. FDA for OST-HER2 in osteosarcoma in 2025 and, if approved, would become eligible to receive a Priority Review Voucher that it could then sell. OST-HER2 has completed a Phase 1 clinical study primarily in breast cancer patients, in addition to showing preclinical efficacy data in various models of breast cancer. OST-HER2 has been conditionally approved by the U.S. Department of Agriculture for the treatment of canines with osteosarcoma. In addition, OS Therapies is advancing its next-generation Antibody Drug Conjugate (ADC) and Drug Conjugates (DC), known as tunable ADC (tADC), which features tunable, tailored antibody-linker-payload candidates. This platform leverages the Company's proprietary silicone Si-Linker and Conditionally Active Payload (CAP) technology, enabling the delivery of multiple payloads per linker. For more information, please visit Forward-Looking Statements Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute forward-looking statements within the meaning of the federal securities laws. These forward-looking statements and terms such as "anticipate," "expect," "intend," "may," "will," "should" or other comparable terms involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding the intent, belief or current expectations of OS Therapies and members of its management, as well as the assumptions on which such statements are based. OS Therapies cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially, including, but not limited to the approval of OST-HER2 by the U.S. FDA and other risks and uncertainties described in 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' in the Company's most recent Annual Report on Form 10-K and other subsequent documents the Company files with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by the federal securities laws, OS Therapies specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
